Prolacta Bioscience: Clinical Trials

2 trials sponsored by Prolacta Bioscience, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 terminated. 2 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Active not recruiting 1, Terminated 1
Phase 31Active not recruiting 1

Follow Prolacta Bioscience: new trials by email

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study To Evaluate The Safety And Efficacy of PBCLN-010 In Combination With PBCLN-014 in Participants Receiving Allogeneic Hematopoietic Cell Transplantation
B. infantis (PBCLN-014) and Human Milk Oligosaccharides (HMO) (PBCLN-010) - Hematologic Malignancy
Phase 2TerminatedProlacta Bioscience462023-09-182024-08-19
Human Milk Fortification in Extremely Preterm Infants
H2MF, Bovine milk-based fortifier - Necrotizing Enterocolitis, Sepsis
Phase 2 / Phase 3Active not recruitingThomas Abrahamsson, MD, PhD2292019-02-012024-07-23

Conditions studied

Enterocolitis, Necrotizing (1)  ·  Hematologic Neoplasms (1)  ·  Sepsis (1)

Interventions

Health Maintenance Organizations (1)

Countries

Sweden (1)  ·  United States (1)

Top investigators

Thomas R Abrahamsson, MD, PhD (1)

Results publications

PMID 34815288, PMID 38545091